BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Landuyt L, Lonigro C, Meuris L, Callewaert N. Customized protein glycosylation to improve biopharmaceutical function and targeting. Current Opinion in Biotechnology 2019;60:17-28. [DOI: 10.1016/j.copbio.2018.11.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Bryan L, Clynes M, Meleady P. The emerging role of cellular post-translational modifications in modulating growth and productivity of recombinant Chinese hamster ovary cells. Biotechnol Adv 2021;49:107757. [PMID: 33895332 DOI: 10.1016/j.biotechadv.2021.107757] [Reference Citation Analysis]
2 Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol 2020;21:729-49. [PMID: 33087899 DOI: 10.1038/s41580-020-00294-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 35.5] [Reference Citation Analysis]
3 O’flaherty R, Bergin A, Flampouri E, Mota LM, Obaidi I, Quigley A, Xie Y, Butler M. Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing. Biotechnology Advances 2020;43:107552. [DOI: 10.1016/j.biotechadv.2020.107552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
4 Kozak S, Bloch Y, De Munck S, Mikula A, Bento I, Savvides SN, Meijers R. Homogeneously N-glycosylated proteins derived from the GlycoDelete HEK293 cell line enable diffraction-quality crystallogenesis. Acta Crystallogr D Struct Biol 2020;76:1244-55. [PMID: 33263330 DOI: 10.1107/S2059798320013753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li D, Lou Y, Zhang Y, Liu S, Li J, Tao J. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Theranostics 2021;11:5430-46. [PMID: 33859756 DOI: 10.7150/thno.53961] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
6 Aquino AK, Manzer ZA, Daniel S, DeLisa MP. Glycosylation-on-a-Chip: A Flow-Based Microfluidic System for Cell-Free Glycoprotein Biosynthesis. Front Mol Biosci 2021;8:782905. [PMID: 35004852 DOI: 10.3389/fmolb.2021.782905] [Reference Citation Analysis]
7 Huang T, Wu Q, Huang H, Zhang C, Wang L, Wang L, Liu Y, Li W, Zhang J, Liu Y. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels. Biochim Biophys Acta Gen Subj 2022;1866:130046. [PMID: 34743989 DOI: 10.1016/j.bbagen.2021.130046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Thooft K, Van Breedam W, Santens F, Wyseure E, Vanmarcke S, Devos S, Callewaert N, Madder A. GlyConnect-Ugi: site-selective, multi-component glycoprotein conjugations through GlycoDelete expressed glycans. Org Biomol Chem 2022;20:464-71. [PMID: 34913461 DOI: 10.1039/d1ob02299g] [Reference Citation Analysis]
9 Narimatsu Y, Büll C, Chen YH, Wandall HH, Yang Z, Clausen H. Genetic glycoengineering in mammalian cells. J Biol Chem 2021;296:100448. [PMID: 33617880 DOI: 10.1016/j.jbc.2021.100448] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Liu H, Ma L, Lin J, Cao B, Qu D, Luo C, Huang W, Han L, Xu H, Wu Z, Xu R, Zhang D. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer. Pharmacol Res 2020;155:104738. [PMID: 32151681 DOI: 10.1016/j.phrs.2020.104738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Radoman B, Grünwald-Gruber C, Schmelzer B, Zavec D, Gasser B, Altmann F, Mattanovich D. The Degree and Length of O-Glycosylation of Recombinant Proteins Produced in Pichia pastoris Depends on the Nature of the Protein and the Process Type. Biotechnol J 2021;16:e2000266. [PMID: 32975831 DOI: 10.1002/biot.202000266] [Reference Citation Analysis]
12 Dehghani J, Adibkia K, Movafeghi A, Maleki-kakelar H, Saeedi N, Omidi Y. Towards a new avenue for producing therapeutic proteins: Microalgae as a tempting green biofactory. Biotechnology Advances 2020;40:107499. [DOI: 10.1016/j.biotechadv.2019.107499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Thaysen-Andersen M, Kolarich D, Packer NH. Glycomics & Glycoproteomics: From Analytics to Function. Mol Omics 2021;17:8-10. [PMID: 33295916 DOI: 10.1039/d0mo90019b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Rexer T, Laaf D, Gottschalk J, Frohnmeyer H, Rapp E, Elling L. Enzymatic Synthesis of Glycans and Glycoconjugates. Adv Biochem Eng Biotechnol 2021;175:231-80. [PMID: 33052414 DOI: 10.1007/10_2020_148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nika L, Cuadrado-Castano S, Asthagiri Arunkumar G, Grünwald-Gruber C, McMahon M, Koczka K, García-Sastre A, Krammer F, Grabherr R. An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model. Vaccines (Basel) 2019;7:E41. [PMID: 31137559 DOI: 10.3390/vaccines7020041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Zhong X, D’antona AM, Scarcelli JJ, Rouse JC. New Opportunities in Glycan Engineering for Therapeutic Proteins. Antibodies 2022;11:5. [DOI: 10.3390/antib11010005] [Reference Citation Analysis]
17 Ruhnau J, Grote V, Juarez-Osorio M, Bruder D, Mahour R, Rapp E, Rexer TFT, Reichl U. Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. Front Bioeng Biotechnol 2021;9:699025. [PMID: 34485255 DOI: 10.3389/fbioe.2021.699025] [Reference Citation Analysis]
18 Li M, Zheng X, Shanker S, Jaroentomeechai T, Moeller TD, Hulbert SW, Koçer I, Byrne J, Cox EC, Fu Q, Zhang S, Labonte JW, Gray JJ, DeLisa MP. Shotgun scanning glycomutagenesis: A simple and efficient strategy for constructing and characterizing neoglycoproteins. Proc Natl Acad Sci U S A 2021;118:e2107440118. [PMID: 34551980 DOI: 10.1073/pnas.2107440118] [Reference Citation Analysis]
19 De Greve H, Virdi V, Bakshi S, Depicker A. Simplified monomeric VHH-Fc antibodies provide new opportunities for passive immunization. Curr Opin Biotechnol 2020;61:96-101. [PMID: 31810049 DOI: 10.1016/j.copbio.2019.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
20 Seo J, Oh D. Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras. Animal Cells and Systems. [DOI: 10.1080/19768354.2022.2079719] [Reference Citation Analysis]
21 Huynh HH, Morita N, Sakamoto T, Katayama T, Miyakawa T, Tanokura M, Chiba Y, Shinkura R, Maruyama JI. Functional production of human antibody by the filamentous fungus Aspergillus oryzae. Fungal Biol Biotechnol 2020;7:7. [PMID: 32514366 DOI: 10.1186/s40694-020-00098-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Leng JX, Ren WW, Li Y, Yang G, Gao XD, Fujita M. Cell engineering for the production of hybrid-type N-glycans in HEK293 cells. J Biochem 2021:mvab051. [PMID: 33878161 DOI: 10.1093/jb/mvab051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 De Bousser E, Meuris L, Callewaert N, Festjens N. Human T cell glycosylation and implications on immune therapy for cancer. Hum Vaccin Immunother 2020;16:2374-88. [PMID: 32186959 DOI: 10.1080/21645515.2020.1730658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Lim J, Kim J, Cha H, Kang S, Han H, Ji M, Cheon S, Kang M, Kim HH, Kim D. Establishment of a glycoengineered CHO cell line for enhancing the antennary structure and sialylation of CTLA4-Ig. Enzyme and Microbial Technology 2022. [DOI: 10.1016/j.enzmictec.2022.110007] [Reference Citation Analysis]